Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 11Unknown 3Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 72Lung Neoplasms 34Squamous Cell Carcinoma of Head and Neck 32Head and Neck Neoplasms 30Urinary Bladder Neoplasms 19Uterine Cervical Neoplasms 18Stomach Neoplasms 17Esophageal Neoplasms 17Small Cell Lung Carcinoma 16Cholangiocarcinoma 16Neoplasm Metastasis 13Ovarian Neoplasms 12Carcinoma, Squamous Cell 11Breast Neoplasms 11Neoplasms 10Mesothelioma, Malignant 9Esophageal Squamous Cell Carcinoma 8Biliary Tract Neoplasms 8Sarcoma 7Fallopian Tube Neoplasms 7Pancreatic Neoplasms 6Mesothelioma 6Adenocarcinoma of Lung 6Adenocarcinoma Of Esophagus 6Recurrence 5Gallbladder Neoplasms 5Carcinoma, Ovarian Epithelial 5Bile Duct Neoplasms 5Triple Negative Breast Neoplasms 4Osteosarcoma 4

Interventions

Rituximab 24Cyclophosphamide 20fludarabine phosphate 16Mycophenolic Acid 13Filgrastim 12Cyclosporine 12Bortezomib 12Antilymphocyte Serum 11Whole-Body Irradiation 10Peripheral Blood Stem Cell Transplantation 10Tacrolimus 9Lenalidomide 9fludarabine 8Radiotherapy 7Methotrexate 7Cord Blood Stem Cell Transplantation 7Melphalan 6Busulfan 6venetoclax 5Etoposide 5tanespimycin 4ibrutinib 4Polymerase Chain Reaction 4Methylprednisolone 4Granulocyte Colony-Stimulating Factor 4Flow Cytometry 4ublituximab 3thymoglobulin 3sargramostim 3carfilzomib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Lymphoma, Mantle-Cell × Cisplatin × Clear all
NCT02983097 2018-01-19

R²-DHAP

Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

Phase 1/2 Terminated
34 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Recurrence, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡